Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Brand Name :
Bumadizona
Synonyms :
bumadizone
Class :
NSAIDs
Dosage Forms & Strengths
inflammation
0.4g orally for every 24 hours as maintenance dose
0.4
g
Orally 
every 24 hours
0.4g orally for every 24 hours as maintenance dose
Data not available
Refer to adult dosing
NSAIDs may enhance the anticoagulant effect of Heparin
NSAIDs may enhance the anticoagulant effect of Heparin
ACE Inhibitors may enhance the adverse/toxic effect of NSAIDs
ACE Inhibitors may enhance the adverse/toxic effect of NSAIDs
ACE Inhibitors may enhance the adverse/toxic effect of NSAIDs
ACE Inhibitors may enhance the adverse/toxic effect of NSAIDs
ACE Inhibitors may enhance the adverse/toxic effect of NSAIDs
When bumadizone is used together with andrographolide, this leads to enhanced risk or seriousness of bleeding
When cefmenoxime is used together with bumadizone, this leads to enhanced risk or seriousness of nephrotoxicity
When bumadizone is used together with proglumetacin, this leads to enhanced risk or seriousness of adverse events
When bumadizone is used together with bufexamac, this leads to enhanced risk or seriousness of adverse outcomes
an increase in the severity of adverse effects can be seen if aceclofenac is taken with bumadizone
the excretory rate of aclidinium may be reduced, leading to high serum levels of aclidinium when combined with bumadizone
the excretory rate of allopurinol may be reduced, leading to high serum levels of allopurinol when combined with bumadizone
an increase in the severity of nephrotoxicity can be seen if acyclovir is taken with bumadizone
the excretory rate of amantadine may be reduced, leading to high serum levels of amantadine when combined with bumadizone
an increased risk of hyperkalemia can be seen when amiodarone is administered with bumadizone
an increase in the severity of adverse effects can be seen if antipyrine is taken with bumadizone
severity of hemorrhage and bleeding can be raised if bumadizone is taken with apixaban
The severity of hypertension can be raised if atropine is taken with bumadizone
the excretory rate of baclofen may be reduced, leading to high serum levels of baclofen when combined with bumadizone
the excretory rate of benorilate may be reduced, leading to high serum levels of benorilate when combined with bumadizone
the neuroexcitatory activity of trovafloxacin may be enhanced with bumadizone
the excretory rate of vancomycin may be reduced, leading to high serum levels of vancomycin when combined with bumadizone
reduction in the protein-binding efficacy of valproic acid can be seen when taken with bumadizone
The severity of hemorrhage and bleeding can be raised if bumadizone is taken with warfarin
When bumadizone is used together with benoxaprofen, this leads to enhanced risk or seriousness of adverse events
bumadizone leads to a reduction in the rate of excretion of eucalyptus oil which leads to increased level of serum
bumadizone leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
bumadizone leads to a reduction in the rate of excretion of pentaerythritol tetranitrate, which leads to an increased level of serum
bumadizone leads to a reduction in the rate of excretion of nitric oxide, which leads to an increased level of serum
When bumadizone is used together with nifenazone, this leads to enhanced risk or seriousness of adverse events
When bumadizone is used together with difenpiramide, this leads to increased risk or seriousness of adverse events
bumadizone may decrease the excretion rate of almasilate, leading to higher serum levels
When bumadizone is used together with diazoxide, this leads to reduction in therapeutic effectiveness of diazoxide
angiotensin II Receptor Blockers may enhance the adverse/toxic effect of Nonsteroidal Anti-Inflammatory Agents
angiotensin II Receptor Blockers may enhance the adverse/toxic effect of Nonsteroidal Anti-Inflammatory Agents
angiotensin II Receptor Blockers may enhance the adverse/toxic effect of Nonsteroidal Anti-Inflammatory Agents
angiotensin II Receptor Blockers may enhance the adverse/toxic effect of Nonsteroidal Anti-Inflammatory Agents
angiotensin II Receptor Blockers may enhance the adverse/toxic effect of Nonsteroidal Anti-Inflammatory Agents
may increase the risk or severity of hypertension when combined
may enhance the risk or severity of hypertension when combined
the rate of excretion of inositol may be reduced
bumadizone might lead to a reduction in the rate of excretion of telavancin, potentially leading to elevated levels of serum
Actions and spectrumÂ
By preventing the release of prostaglandins which are known to cause fever, inflammation, and pain. It helps in decreasing the pain and inflammation.Â
Frequency not definedÂ
DizzinessÂ
NauseaÂ
HeadacheÂ
Renal failureÂ
Gastrointestinal bleedingÂ
Black Box Warning
Not listed
Contraindication/Caution:
Contraindication:
Hypersensitivity
Formation of peptic ulcers
Liver failure
Renal failure
Pregnancy consideration:
USFDA pregnancy category: not recommended in the third trimester of pregnancyÂ
Lactation:
Safety data not establishedÂ
Pregnancy category:
Category A:Â Studies that were well-controlled and met expectations revealed no risk to the fetus `in either the first or second trimester.
Category B: There were a lack of studies on pregnant women and no evidence of risk to the fetus in animal experiments.
Category C:Â there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.
Category D:Â adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh the risks over benefits. Hence, these categories of drugs need to be avoided by pregnant women.
Category N:Â There is no data available for the drug under this category
PharmacologyÂ
It helps in reducing the inflammation and pain by preventing the synthesis of prostaglandins.Â
PharmacodynamicsÂ
It inhibits the cyclooxygenase COX-1 and COX-2 enzymes which leads to the reduction of prostaglandinsÂ
PharmacokineticsÂ
Not much data available on the ADMEÂ
AdministrationÂ
Not enough information available on the administrationÂ
Patient information leafletÂ
Generic Name: bumadizoneÂ
Why do we use bumadizone?Â
It is recommended to treat rheumatoid arthritis pain. It also helps reducing fever and acts as an antipyretic.Â